AI assistant
Sending…
Veradermics, Inc — Director's Dealing 2026
Feb 6, 2026
51537_dirs_2026-02-05_ec565338-930d-4272-8ab8-ecf32f5d7b3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Veradermics, Inc (MANE)
CIK: 0001827635
Period of Report: 2026-02-03
Reporting Person: Pance Katarina (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | Stock Option (Right to Buy) | $17.00 | A | 43000 | Acquired | 2036-02-03 | Common Stock (43000) | Direct |
Footnotes
F1: This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.
More from Veradermics, Inc
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
May 12
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 27
Capital/Financing Update
2026
Apr 27
Regulatory Filings
2026
Apr 27
Investor Presentation
2026
Apr 27
Earnings Release
2026
Mar 30
Director's Dealing
2026
Feb 10